| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 177,142 | 197,722 | 134,892 | 126,092 | | Cost of Revenue | 87,344 | 96,610 | 85,161 | 70,048 | | | Gross Profit | 89,798 | 101,112 | 49,731 | 56,044 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 78,403 | 96,113 | 72,187 | 97,576 | | Non Recurring | 1,686 | 29,570 | 107 | 1,378 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,709 | (24,571) | (22,563) | (42,910) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 196 | 2,418 | 1,052 | (217) | | Earnings Before Interest And Taxes | 9,905 | (22,153) | (21,511) | (43,127) | | Interest Expense | 155 | 561 | 696 | 408 | | Income Before Tax | 9,750 | (22,714) | (22,207) | (43,535) | | Income Tax Expense | (12,318) | 7,567 | 210 | (8,833) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 22,068 | (30,281) | (22,417) | (34,702) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 22,068 | (30,281) | (22,417) | (34,702) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $22,068 | ($30,281) | ($22,417) | ($34,702) |
|
0.01% Nasdaq 
0.22%
Income Statement
